Showing results (1-10 of 1,875) with videos related to

Sort By:
Pageof 188
Therapeutic Advances in Medical Oncology|December 8, 2022
Immune checkpoint inhibitors in resectable gastroesophageal cancers - a reviewSarbajit Mukherjee, Kanak Parmar, Elizabeth Smyth
Therapeutic Advances in Medical Oncology|November 24, 2022
Immune checkpoint inhibitors plus chemotherapy in patients with locally advanced or metastatic pulmonary sarcomatoid carcinoma: a multicentric real-world studyFei Zhou, Haoyue Guo, Xiaolong Zhou, et al.
Therapeutic Advances in Medical Oncology|October 16, 2020
Outcome of oncological patients admitted with COVID-19: experience of a hospital center in northern ItalySara Cherri, Daniel H L Lemmers, Silvia Noventa, et al.
Therapeutic Advances in Medical Oncology|March 28, 2020
PARP inhibitor combinations in prostate cancerCarmel Pezaro
Therapeutic Advances in Medical Oncology|March 28, 2020
Split chimeric antigen receptor-modified T cells targeting glypican-3 suppress hepatocellular carcinoma growth with reduced cytokine releaseXuan Liu, Jianyun Wen, Honglei Yi, et al.
Therapeutic Advances in Medical Oncology|March 5, 2020
Biomarker testing for personalized, first-line therapy in advanced nonsquamous non-small cell lung cancer patients in the real world setting in Japan: a retrospective, multicenter, observational study (the BRAVE study)Junichi Shimizu, Katsuhiro Masago, Haruhiro Saito, et al.
Therapeutic Advances in Medical Oncology|March 5, 2020
Chinese consensus on the diagnosis and treatment of gastric cancer with liver metastasesKecheng Zhang, Lin Chen
Therapeutic Advances in Medical Oncology|September 14, 2020
Microvascular density assessed by CD31 predicts clinical benefit upon bevacizumab treatment in metastatic colorectal cancer: results of the PassionATE study, a translational prospective Phase II study of capecitabine and irinotecan plus bevacizumab followed by capecitabine and oxaliplatin plus bevacizumab or the reverse sequence in patients in mCRCDaniela Bianconi, Merima Herac, Florian Posch, et al.
Therapeutic Advances in Medical Oncology|March 29, 2020
An open label, multicenter, noninterventional study of apatinib in advanced gastric cancer patients (AHEAD-G202)Xiang Wang, Ruixing Zhang, Nan Du, et al.
Therapeutic Advances in Medical Oncology|July 15, 2021
Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysisJun Yin, Shaheenah Dawood, Romain Cohen, et al.
Pageof 188